Time to Buy Beat-Down Bionano Genomics Inc. (BNGO) Stock? Here is the INSIGHT – Invest Chronicle

Time to Buy Beat-Down Bionano Genomics Inc. (BNGO) Stock? Here is the INSIGHT

For the readers interested in the stock health of Bionano Genomics Inc. (BNGO). It is currently valued at $6.37. When the transactions were called off in the previous session, Stock hit the highs of $6.78, after setting-off with the price of $6.50. Company’s stock value dipped to $6.33 during the trading on the day. When the trading was stopped its value was $6.61.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Recently in News on April 22, 2021, Bionano Genomics Announces Publication of New Approach to Study DNA Replication Using Optical Genome Mapping With Saphyr, Potentially Supporting Development of Cancer Drugs Targeting Replication Pathways. Publication on novel Saphyr-based method to analyze DNA replication in human genomes could enable new level of cancer research and drug discovery, exemplifies the importance of optical genome mapping in large research market. You can read further details here

A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .


Bionano Genomics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $15.69 on 02/16/21, with the lowest value was $3.91 for the same time period, recorded on 01/08/21.

Bionano Genomics Inc. (BNGO) full year performance was 1477.90%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Bionano Genomics Inc. shares are logging -59.40% during the 52-week period from high price, and 1801.49% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.34 and $15.69.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 15204613 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Bionano Genomics Inc. (BNGO) recorded performance in the market was 106.82%, having the revenues showcasing -42.35% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.84B, as it employees total of 147 workers.

Specialists analysis on Bionano Genomics Inc. (BNGO)

During the last month, 0 analysts gave the Bionano Genomics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 7.30, with a change in the price was noted +5.87. In a similar fashion, Bionano Genomics Inc. posted a movement of +1,169.43% for the period of last 100 days, recording 64,511,984 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for BNGO is recording 0.46 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.46.

Trends and Technical analysis: Bionano Genomics Inc. (BNGO)

Raw Stochastic average of Bionano Genomics Inc. in the period of last 50 days is set at 13.54%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 40.19%. In the last 20 days, the company’s Stochastic %K was 47.03% and its Stochastic %D was recorded 54.45%.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 106.82%. Additionally, trading for the stock in the period of the last six months notably improved by 1154.93%, alongside a boost of 1477.90% for the period of the last 12 months. The shares increased approximately by 3.41% in the 7-day charts and went up by -21.16% in the period of the last 30 days. Common stock shares were lifted by -42.35% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.